학술논문
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma
Document Type
Article
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia August 2022 22(8):618-625
Subject
Language
ISSN
2152-2650